This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nike, FedEx, Costco, Oracle and Adobe are part of Zacks Earnings Preview
by Zacks Equity Research
Nike, FedEx, Costco, Oracle and Adobe are part of Zacks Earnings Preview.
Looking Ahead to the Q1 Earnings Season
by Sheraz Mian
The Q1 reporting cycle will really get going when the big banks come out with their March-quarter results on April 11th. What should investors know heading into the period?
Oracle Launches AI Centre in Southeast Asia to Steer Competition
by Zacks Equity Research
ORCL's AI Centre can't hide missed earnings, falling license revenues, and fierce regional competition from AWS, Microsoft and Google.
Oracle Corporation (ORCL) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Oracle (ORCL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
International Markets and Oracle (ORCL): A Deep Dive for Investors
by Zacks Equity Research
Explore Oracle's (ORCL) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Company News for Mar 12, 2025
by Zacks Equity Research
Companies in The News Are: FRG, ORCL, LEGN, PAY
Oracle Trips on Q3 Earnings & Sales Miss: Buy, Sell or Hold the Stock?
by Vasundhara Sawalka
ORCL's missed Q3 targets expose an overvalued tech giant with slowing growth. Sell the stock now before the premium multiple collapses.
Oracle Stock Stumbles on Q3 Earnings Miss, Revenues Rise Y/Y
by Zacks Equity Research
ORCL's fiscal third-quarter results reflect strength in the cloud infrastructure segment due to demand for computing power that can support AI projects.
Is It Worth Investing in Oracle (ORCL) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Oracle (ORCL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
"R-Word" Fears Send Stock Market Much Lower
by Mark Vickery
While the tech-heavy Nasdaq and small-cap Russell 2000 are both -11% over the past month, the Dow is down "only" half that.
Oracle (ORCL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Oracle (ORCL) give a sense of how the business performed in the quarter ended February 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Oracle (ORCL) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Oracle (ORCL) delivered earnings and revenue surprises of -0.68% and 1.59%, respectively, for the quarter ended February 2025. Do the numbers hold clues to what lies ahead for the stock?
Is Oracle (ORCL) a 'Buy' Ahead of Fiscal Q3 Earnings Announcement?
by Bryan Hayes
Shares have plunged more than 20% from their November 2024 highs.
Costco, AutoZone, Oracle and Adobe are part of Zacks Earnings Preview
by Zacks Equity Research
Costco, AutoZone, Oracle and Adobe are highlights of Zacks Earnings Preview article.
Pre-Markets Open Low-Data Week in the Red
by Zacks Equity Research
Pre-Markets Open Low-Data Week in the Red
Pre-Markets Down Again to Start a New Trading Week
by Mark Vickery
Market indexes last week came in anywhere from -2.25% (Dow) to -3.25% (Nasdaq), and are pointing lower ahead of the open Monday.
Previewing the 2025 Q1 Earnings Season
by Sheraz Mian
The current expectation is that Q1 earnings will be up +6.2% from the same period last year on +3.8% higher revenues, continuing the growth pace nicely. What else should investors know?
Unlocking Q3 Potential of Oracle (ORCL): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Oracle (ORCL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended February 2025.
Should You Invest in MSFT on Dragon Copilot Healthcare AI Innovation?
by Vasundhara Sawalka
Microsoft's Dragon Copilot shows promise, but premium valuation and AI capacity constraints suggest waiting for better entry points in the rest of 2025.
Freshworks Rises 41% in 6 Months: Is the Stock Still Worth Buying?
by Subham Roy
FRSH is rapidly expanding its market share on the back of its extensive offerings built on a unified platform, reducing costs for organizations adopting them.
Synopsys (SNPS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 7.83% and 0.16%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Is ORCL Stock a Buy, Sell or Hold at an EV/EBITDA Multiple of 21.89X?
by Vasundhara Sawalka
Oracle's cloud growth impresses, but rich valuation warrants caution. You can hold or wait for better entry points in 2025 as competition and high capex unfold.
Oracle (ORCL) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
In the most recent trading session, Oracle (ORCL) closed at $168.54, indicating a -0.84% shift from the previous trading day.
Palantir Stock Up 283% in a Year: Is There Still a Buy Opportunity?
by Shuvra Shankar Dey
Given PLTR's remarkable surge in stock price, it's essential to evaluate its current standing and determine whether it remains a compelling investment choice.
Investors Heavily Search Oracle Corporation (ORCL): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Oracle (ORCL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.